NIAID Banner Logo Image

Fungal Drugs in Development (Archived)


OrganismDrug ClassCompanyDrug NameAlt NameDrug StatusNotesAIDS#
Aspergillus spp.CombinationPfizerEraxis™ and Vfend™Anidulafungin and VoriconazolePhase 3Completed 549947
Aspergillus spp.Wall/Membrane DisruptorBasilea PharmaceuticaCresemba™Isavuconazole; ASP9766; BAL-4815; BAL-8557(pro-drug)FDA Approved in 2015  416566
Aspergillus spp.Wall/Membrane DisruptorGilead Sciences; Nexstar PharmaceuticalsNebulised Ambisome™Nebulised Liposomal Amphotericin BPhase 2/3Recruiting 000096
Aspergillus spp.Wall/Membrane DisruptorKaken Pharmaceutical Co.SPK-843SPA-S-843Phase 3Unknown 121440
Candida spp.Cell wall synthesis inhibitorScynexis, Inc.SCY-078MK-3118Phase 2Recruiting 
Candida spp.CombinationAlmirall, S.A.LAS41003LAS189962 and LAS189961Phase 2Completed 
Candida spp.CombinationMethylGeneMGCD290 and FluconazoleMG-3290 and FluconazolePhase 2Completed 496028
Candida spp.Enhance inflammatory responseAM-PharmaHuman LactoferrinhLF1-11Phase 1/2Terminated 028450
Candida spp.Leucyl-tRNA synthetase inhibitorAnacor PharmaceuticalsAN-2718 Phase 1Completed 471686
Candida spp.Sterol demethylase inhibitorPalau Pharma/GlaxoSmithKlineAlbaconazoleUR-9825, W-0027Phase 2Completed 024107
Candida spp.Sterol demethylase inhibitorViamet Pharmaceuticals, Inc.VT-1161 Phase 2Completed 
Candida spp.Wall/Membrane DisruptorFerrer Internacional S.A.ArasertaconazoleR-isomer of SertaconazolePhase 2Completed 008889
Candida spp.Wall/Membrane DisruptorPacgen BiopharmaceuticalsPAC-113 Phase 2Completed 
Cryptococcus spp.UnknownAlkermesLobradimilRMP-7Phase 1Completed 
Cryptococcus spp.Wall/Membrane DisruptorSchering-PloughGenaconazoleSCH 39304; SM-8668Phase 1Completed 007341
Cryptococcus spp.Wall/Membrane DisruptorKaken Pharmaceutical Co.; Proaparts srl SPK-843SPA-S-843Phase 3Unknown 121440
Pneumocystis jiroveciiCombinationGlaxoSmithKlineClindamycin and Primaquine Phase 3Completed 000295
Pneumocystis jiroveciiCombinationGlaxoSmithKlineDapsone and Trimethoprim Phase 3Completed 000310
Pneumocystis jiroveciiDNA Synthesis InhibitorImmtech Pharmaceuticals, IncPafuramidine maleateDB289; Prodrug of DB75Phase 3Terminated 022387
Pneumocystis jiroveciiSuccinate Dehydrogenase InhibitorGlaxoSmithKlineSitamaquineWR 6026Phase 2Completed 007904

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019